Management and  Board of directors

Management and Board of directors

Management and  Board of directors

At InProTher, we challenge biotechnology as we know it by shifting the paradigm in cancer immunotherapy. We have established a great team of scientists, advisors and entrepreneurs with long-standing experience to drive our research every day.

Management Team

Jordi Naval, MSc

Chief Executive Officer

Jordi is an experienced biotech CEO (+20 years), with a track record in early-stage development. Jordi has raised more than 80M in private and public funding for 5 biotechs in several European Countries.

Peter Holst, MD, PhD

Chief Scientific Officer

Dr. Holst is the founder of InProTher and has a long-standing experience within immunology and has made pivotal discoveries in these fields. He has taken virus-vectored vaccines further by developing the first clinically effective genetic adjuvants. Peter Holst’s prior inventions are in clinical trials and licensed to GSK.

Hamina Patel, MD, PhD

Chief Medical Officer

A decisive and energetic physician and C level pharmaceutical executive with over 20 years of experience within the industry with a proven track record of leadership, clinical development in oncology, and global commercial success.

Jan Villadsen

Chief Financial Officer

Extensive experience as a CFO, Finance, Treasury and Corporate Banking executive. Unique combination of senior positions from the corporate sector as well as the financial sector. Deep strategic as well as hands-on operational and analytical capabilities of the entire value chain of complex operations

Board of Directors

Sven Rohmann, MD, PhD, MBA

Chairman of the Board of Directors

Thorough know-how and track record in General Management and Leadership. Successful in Raising Funds for SMEs and public companies. International experience in M&A, Business and Corporate Development. Extensive, international experience in Clinical Development and Exceptional skills in Strategic Marketing and Portfolio Management. Substantial, international experience in small and large scale Venture Capital Financing.

Peter Holst, MD, PhD

Member of the Board of Directors

Nicolaj Højer Nielsen, MBA

Member of the Board of Directors

Nicolaj Højer Nielsenis a serial entrepreneur with +15 years of experience in bringing innovative products to the market, building up management teams and securing project funding. His prior career includes positions at Foss and ALK-Abello and assignments for leading biotech companies including Bavarian Nordic.

Jesper Zeuthen

Member of the Board of Directors

Jesper served as managing director of a large dedicated biotech venture fund in 2000 and was instrumental in Genmab, where he served as Chairman from inception to a highly successfulI PO.

Christian Thirion

Member of the Board of Directors

Managing director and founder SIRION-BIOTECH GmbH, a technology leader in the field of viral vector development and cell modeling for preclinical research and drug development.

Management Team

Jordi Naval, MSc

Chief Executive Officer

Peter Holst, MD, PhD

Chief Scientific Officer

Hamina Patel, MD, PhD

Chief Medical Officer

Jan Villadsen

Chief Financial Officer

Board of Directors

Sven Rohmann, MD, PhD, MBA

Chairman of the Board of Directors

Peter Holst, MD, PhD

Member of the Board of Directors

Nicolaj Højer Nielsen, MBA

Member of the Board of Directors

Jesper Zeuthen

Member of the Board of Directors

Jesper served as managing director of a large dedicated biotech venture fund in 2000 and was instrumental in Genmab, where he served as Chairman from inception to a highly successfulI PO.

Christian Thirion

Member of the Board of Directors

Managing director and founder SIRION-BIOTECH GmbH, a technology leader in the field of viral vector development and cell modeling for preclinical research and drug development.